{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:44:10Z","timestamp":1782776650914,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Talent Start-up Research Program","award":["No. KYQD20240501"],"award-info":[{"award-number":["No. KYQD20240501"]}]},{"name":"Research Project of the Zhejiang Provincial Department of Education","award":["No. Y202457120"],"award-info":[{"award-number":["No. Y202457120"]}]},{"name":"the Science and Technology Plan Project of Wenzhou Municipality","award":["No. Y20240058"],"award-info":[{"award-number":["No. Y20240058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05160-4","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:43:37Z","timestamp":1778082217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional immune ecological subtyping identifies RUNX1 as a prognostic factor in uveal melanoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Wen-Qing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng-Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Qin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"5160_CR1","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.preteyeres.2019.100800","volume":"75","author":"KN Smit","year":"2020","unstructured":"Smit KN, Jager MJ, de Klein A, et al. Uveal melanoma: Towards a molecular understanding. Prog Retin Eye Res. 2020;75:100800. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100800.","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"5160_CR2","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(11):4651\u20139. https:\/\/doi.org\/10.1167\/iovs.03-0538.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"5160_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24. https:\/\/doi.org\/10.1038\/s41572-020-0158-0.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"5160_CR4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jvir.2018.04.030","volume":"29","author":"J Zheng","year":"2018","unstructured":"Zheng J, Irani Z, Lawrence D, et al. Combined effects of Yttrium-90 transarterial radioembolization around immunotherapy for hepatic metastases from uveal melanoma: a preliminary retrospective case series. J Vasc Interv Radiol. 2018;29(10):1369\u201375. https:\/\/doi.org\/10.1016\/j.jvir.2018.04.030.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"5160_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.hpb.2019.11.002","volume":"22","author":"A Rowcroft","year":"2020","unstructured":"Rowcroft A, Loveday BPT, Thomson BNJ, et al. Systematic review of liver directed therapy for uveal melanoma hepatic metastases. HPB (Oxford). 2020;22(4):497\u2013505. https:\/\/doi.org\/10.1016\/j.hpb.2019.11.002.","journal-title":"HPB (Oxford)"},{"key":"5160_CR6","doi-asserted-by":"publisher","unstructured":"Thorsson V, Gibbs DL, Brown SD et al. The immune landscape of cancer. Immunity, 2018. 48(4): pp. 812\u2013830 ehttps:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","DOI":"10.1016\/j.immuni.2018.03.023"},{"issue":"1","key":"5160_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines6010014","volume":"6","author":"A Cesano","year":"2018","unstructured":"Cesano A, Warren S. Bringing the next generation of immuno-oncology biomarkers to the clinic. Biomedicines. 2018;6(1):14. https:\/\/doi.org\/10.3390\/biomedicines6010014.","journal-title":"Biomedicines"},{"key":"5160_CR8","doi-asserted-by":"publisher","first-page":"973073","DOI":"10.3389\/fcell.2022.973073","volume":"10","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chen X, Wang X. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma. Front Cell Dev Biol. 2022;10:973073. https:\/\/doi.org\/10.3389\/fcell.2022.973073.","journal-title":"Front Cell Dev Biol"},{"issue":"25","key":"5160_CR9","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1097\/md.0000000000042574","volume":"104","author":"Y Tao","year":"2025","unstructured":"Tao Y, Peng Y, Zhu H, et al. Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational study. Med (Baltim). 2025;104(25):e. https:\/\/doi.org\/10.1097\/md.0000000000042574.","journal-title":"Med (Baltim)"},{"issue":"6","key":"5160_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.ophtha.2013.12.014","volume":"121","author":"JW Harbour","year":"2014","unstructured":"Harbour JW, Chao DL. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology. 2014;121(6):1281\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2013.12.014.","journal-title":"Ophthalmology"},{"issue":"2","key":"5160_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.18632\/aging.102693","volume":"12","author":"H Pan","year":"2020","unstructured":"Pan H, Lu L, Cui J, et al. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis. Aging. 2020;12(2):1446\u201364. https:\/\/doi.org\/10.18632\/aging.102693.","journal-title":"Aging"},{"key":"5160_CR12","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/s41418-025-01469-9","volume":"32","author":"D Delgado-Bellido","year":"2025","unstructured":"Delgado-Bellido D, Chacon-Barrado A, Olmedo-Pelayo J, et al. Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2\u03b1 and VE-cadherin activation in uveal melanoma. Cell Death Differ. 2025;32:1473\u201383. https:\/\/doi.org\/10.1038\/s41418-025-01469-9.","journal-title":"Cell Death Differ"},{"key":"5160_CR13","doi-asserted-by":"publisher","first-page":"666462","DOI":"10.3389\/fcell.2021.666462","volume":"9","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Su J, Li L, et al. Identification of precise therapeutic targets and characteristic prognostic genes based on immune gene characteristics in uveal melanoma. Front Cell Dev Biol. 2021;9:666462. https:\/\/doi.org\/10.3389\/fcell.2021.666462.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5160_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13046-021-01947-1","volume":"40","author":"A Tosi","year":"2021","unstructured":"Tosi A, Cappellesso R, Dei Tos AP, et al. The immune cell landscape of metastatic uveal melanoma correlates with overall survival. J Exp Clin Cancer Res. 2021;40(1):154. https:\/\/doi.org\/10.1186\/s13046-021-01947-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5160_CR15","doi-asserted-by":"publisher","first-page":"9146","DOI":"10.1038\/s41598-024-59827-5","volume":"14","author":"M Zhao","year":"2024","unstructured":"Zhao M, Yu Y, Song Z. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients. Sci Rep. 2024;14(1):9146. https:\/\/doi.org\/10.1038\/s41598-024-59827-5.","journal-title":"Sci Rep"},{"key":"5160_CR16","doi-asserted-by":"publisher","first-page":"109214","DOI":"10.1016\/j.exer.2022.109214","volume":"223","author":"X Zhang","year":"2022","unstructured":"Zhang X, Qiu J, Huang F, et al. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses. Exp Eye Res. 2022;223:109214. https:\/\/doi.org\/10.1016\/j.exer.2022.109214.","journal-title":"Exp Eye Res"},{"key":"5160_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2022.07.031","volume":"174","author":"P Donizy","year":"2022","unstructured":"Donizy P, Krzyzinski M, Markiewicz A, et al. Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma. Eur J Cancer. 2022;174:251\u201360. https:\/\/doi.org\/10.1016\/j.ejca.2022.07.031.","journal-title":"Eur J Cancer"},{"issue":"11","key":"5160_CR18","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1371\/journal.pone.0015543","volume":"5","author":"Y Hoshida","year":"2010","unstructured":"Hoshida Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE. 2010;5(11):e. https:\/\/doi.org\/10.1371\/journal.pone.0015543.","journal-title":"PLoS ONE"},{"key":"5160_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, et al. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12.","journal-title":"Methods Mol Biol"},{"key":"5160_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7. GSVA: gene set variation analysis for microarray and RNA-seq data."},{"key":"5160_CR21","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"issue":"14","key":"5160_CR22","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/1878-0261.13210","volume":"16","author":"RS Adam","year":"2022","unstructured":"Adam RS, Poel D, Ferreira Moreno L, et al. Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes. Mol Oncol. 2022;16(14):2693\u2013709. https:\/\/doi.org\/10.1002\/1878-0261.13210.","journal-title":"Mol Oncol"},{"issue":"7","key":"5160_CR23","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5160_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7150\/jca.90990","volume":"15","author":"Y Xie","year":"2024","unstructured":"Xie Y, Pan X, Wang Z, et al. Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinations. J Cancer. 2024;15(3):776\u201395. https:\/\/doi.org\/10.7150\/jca.90990.","journal-title":"J Cancer"},{"key":"5160_CR25","doi-asserted-by":"crossref","unstructured":"Smyth GK. Limma: linear models for microarray data, in Bioinformatics and computational biology solutions using R and Bioconductor. Springer; 2005. pp. 397\u2013420.","DOI":"10.1007\/0-387-29362-0_23"},{"issue":"1","key":"5160_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-8794-3-21","volume":"3","author":"A Gribov","year":"2010","unstructured":"Gribov A, Sill M, L\u00fcck S, et al. SEURAT: visual analytics for the integrated analysis of microarray data. BMC Med Genomics. 2010;3(1):21. https:\/\/doi.org\/10.1186\/1755-8794-3-21.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"5160_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"5160_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mrd.22489","volume":"82","author":"J Schindelin","year":"2015","unstructured":"Schindelin J, Rueden CT, Hiner MC, et al. The ImageJ ecosystem: An open platform for biomedical image analysis. Mol Reprod Dev. 2015;82:7\u20138. https:\/\/doi.org\/10.1002\/mrd.22489.","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"5160_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41420-024-01963-y","volume":"10","author":"HE Bi","year":"2024","unstructured":"Bi HE, Zhang J, Yao Y, et al. Expression and functional significance of phosphoenolpyruvate carboxykinase 1 in uveal melanoma. Cell Death Discov. 2024;10(1):196. https:\/\/doi.org\/10.1038\/s41420-024-01963-y.","journal-title":"Cell Death Discov"},{"issue":"1","key":"5160_CR30","doi-asserted-by":"publisher","first-page":"23280","DOI":"10.1038\/s41598-024-73655-7","volume":"14","author":"Q Yu","year":"2024","unstructured":"Yu Q, Xu S, Weng S, et al. GREM1 may be a biological indicator and potential target of bladder cancer. Sci Rep. 2024;14(1):23280. https:\/\/doi.org\/10.1038\/s41598-024-73655-7.","journal-title":"Sci Rep"},{"key":"5160_CR31","doi-asserted-by":"publisher","first-page":"111987","DOI":"10.1016\/j.cellsig.2025.111987","volume":"135","author":"S Liu","year":"2025","unstructured":"Liu S, Su H, Wang X, et al. High expression of CHEK2 promotes tumor progression in kidney renal clear cell carcinoma through targeting TEAD4 signaling pathway. Cell Signal. 2025;135:111987. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111987.","journal-title":"Cell Signal"},{"key":"5160_CR32","doi-asserted-by":"publisher","unstructured":"Lu X, Meng J, Zhou Y et al. MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics, 2021. 36(22\u201323): pp. 5539\u20135541.https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018","DOI":"10.1093\/bioinformatics\/btaa1018"},{"issue":"10","key":"5160_CR33","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/sj.bjc.6601374","volume":"89","author":"W Zuidervaart","year":"2003","unstructured":"Zuidervaart W, van der Velden PA, Hurks MH, et al. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br J Cancer. 2003;89(10):1914\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6601374.","journal-title":"Br J Cancer"},{"issue":"17","key":"5160_CR34","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.3390\/cancers14174105","volume":"14","author":"YC Cole","year":"2022","unstructured":"Cole YC, Zhang YZ, Gallo B, et al. Correlation between BAP1 localization, driver mutations, and patient survival in uveal melanoma. Cancers (Basel). 2022;14(17):4105. https:\/\/doi.org\/10.3390\/cancers14174105.","journal-title":"Cancers (Basel)"},{"key":"5160_CR35","doi-asserted-by":"publisher","unstructured":"Conway E, Rossi F, Fernandez-Perez D et al. BAP1 enhances Polycomb repression by counteracting widespread H2AK119ub1 deposition and chromatin condensation. Mol Cell, 2021. 81(17): pp. 3526\u20133541 ehttps:\/\/doi.org\/10.1016\/j.molcel.2021.06.020","DOI":"10.1016\/j.molcel.2021.06.020"},{"issue":"8","key":"5160_CR36","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1541-7786.MCR-21-0657","volume":"20","author":"U Baqai","year":"2022","unstructured":"Baqai U, Purwin TJ, Bechtel N, et al. Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma. Mol Cancer Res. 2022;20(8):1260\u201371. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0657.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"5160_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13073-019-0631-0","volume":"11","author":"M Ladanyi","year":"2019","unstructured":"Ladanyi M, Sanchez Vega F, Zauderer M. Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma. Genome Med. 2019;11(1):18. https:\/\/doi.org\/10.1186\/s13073-019-0631-0.","journal-title":"Genome Med"},{"issue":"1","key":"5160_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s40820-024-01455-9","volume":"16","author":"T Meng","year":"2024","unstructured":"Meng T, He D, Han Z, et al. Nanomaterial-based repurposing of macrophage metabolism and its applications. Nanomicro Lett. 2024;16(1):246. https:\/\/doi.org\/10.1007\/s40820-024-01455-9.","journal-title":"Nanomicro Lett"},{"issue":"7","key":"5160_CR39","doi-asserted-by":"publisher","first-page":"bqae","DOI":"10.1210\/endocr\/bqae069","volume":"165","author":"G Chen","year":"2024","unstructured":"Chen G, Yu Y, Zhu Y, et al. Cenicriviroc suppresses and reverses steatohepatitis by regulating macrophage infiltration and M2 polarization in mice. Endocrinology. 2024;165(7):bqae. https:\/\/doi.org\/10.1210\/endocr\/bqae069.","journal-title":"Endocrinology"},{"issue":"1","key":"5160_CR40","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1186\/s12967-025-07262-z","volume":"23","author":"YZ Sun","year":"2025","unstructured":"Sun YZ, Zou DD, Li XJ, et al. Multi-omics analysis reveals the crosstalk of epigenetic regulatory networks in cutaneous squamous cell carcinoma progression. J Transl Med. 2025;23(1):1281. https:\/\/doi.org\/10.1186\/s12967-025-07262-z.","journal-title":"J Transl Med"},{"issue":"1","key":"5160_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10238-025-01825-6","volume":"25","author":"Y Luo","year":"2025","unstructured":"Luo Y, Wang R, Xu Y, et al. Notch pathway defines an aggressive and immune-suppressive phenotype associated with checkpoint inhibitor resistance in pan-gastrointestinal adenocarcinomas. Clin Exp Med. 2025;25(1):340. https:\/\/doi.org\/10.1007\/s10238-025-01825-6.","journal-title":"Clin Exp Med"},{"key":"5160_CR42","doi-asserted-by":"publisher","unstructured":"Zezulin AU, Yen D, Ye D et al. RUNX1 is required in granulocyte-monocyte progenitors to attenuate inflammatory cytokine production by neutrophils. Genes Dev, 2023. 37(13\u201314): pp. 605\u2013620.https:\/\/doi.org\/10.1101\/gad.350418.123","DOI":"10.1101\/gad.350418.123"},{"issue":"10","key":"5160_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati L, Carradori G, Scherz-Shouval R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat Rev Cancer. 2024;24(10):676\u201393. https:\/\/doi.org\/10.1038\/s41568-024-00740-4.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5160_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","volume":"22","author":"L Pei","year":"2023","unstructured":"Pei L, Liu Y, Liu L, et al. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer. 2023;22(1):29. https:\/\/doi.org\/10.1186\/s12943-023-01731-z.","journal-title":"Mol Cancer"},{"key":"5160_CR45","doi-asserted-by":"publisher","first-page":"1099071","DOI":"10.3389\/fimmu.2023.1099071","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Zhao H, Wang S. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data. Front Immunol. 2023;14:1099071. https:\/\/doi.org\/10.3389\/fimmu.2023.1099071.","journal-title":"Front Immunol"},{"issue":"4","key":"5160_CR46","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.011.","journal-title":"Cancer Cell"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05160-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:48:46Z","timestamp":1782773326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05160-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5160"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05160-4","relation":{"references":[{"id-type":"doi","id":"10.1186\/1471-2105-14-7IF:","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Eye Hospital of Wenzhou Medical University (Approval No. 2025-299-K-250) and conducted in accordance with institutional guidelines and national regulations. Archived human tissue samples were used, and informed written consent was obtained from all participants involved in the studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"944"}}